2003Unpublished venueRequires access

Oestrogen plus progestin doubles the risk of dementia in post-menopausal women Shumaker S, Legault C, Rapp S et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the women's health initiative memory study: a randomized controlled trial.

Piedmont Plaza

Open publisher page 0 citations

Abstract

5the beneficial effect of estrogen on psychological and cognitive function. We need to await the outcome of the unopposed arm of the WHIMS trial to determine whether medroxyprogesterone acetate was influential in the negative findings of the hormone therapy arm of this study. Second, 80% of the WHIMS sample were hormone naive, and started hormone therapy at a mean age of approximately 70 years. Both animal and human studies provide evidence that estrogen protects cognitive function when treatment is initiated soon after ovariectomy in rats 6

About this research paper

What this paper is about

5the beneficial effect of estrogen on psychological and cognitive function. We need to await the outcome of the unopposed arm of the WHIMS trial to determine whether medroxyprogesterone acetate was influential in the negative findings of the hormone therapy arm of this study. Second, 80% of the WHIMS sample were hormone naive, and started hormone therapy at a mean age of approximately 70 years. Both animal and human studies provide evidence that estrogen protects cognitive function when treatment is initiated soon after ovariectomy in rats 6

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

5the beneficial effect of estrogen on psychological and cognitive function. We need to await the outcome of the unopposed arm of the WHIMS trial to determine whether medroxyprogesterone acetate was influential in the negative findings of the hormone therapy arm of this study. Second, 80% of the WHIMS sample were hormone naive, and started hormone therapy at a mean age of approximately 70 years. Both animal and human studies provide evidence that estrogen protects cognitive function when treatment is initiated soon after ovariectomy in rats 6

Key concepts: Medroxyprogesterone acetate, Progestin, Estrogen, Medicine, Dementia, Menopause, Hormone therapy, Medroxyprogesterone

Related papers

Back to paper searchBrowse research topicsOriginal source
Oestrogen plus progestin doubles the risk of dementia in post-menopausal women Shumaker S, Legault C, Rapp S et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the women's health initiative memory study: a randomized controlled trial. — Research Paper | ScholarLens